Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Molding as Innovative Technology for Personalized Tablet Production

Author(s):  Mady Omar Y, Al-Shoubki Adam A, Hagag Youssef, Ibrahim Bakry, Donia Ahmed A

Issue:  Mar/Apr 2022 - Volume 26, Number 2
View All Articles in Issue

Page(s):  163-174

Molding as Innovative Technology for Personalized Tablet Production Page 1
Molding as Innovative Technology for Personalized Tablet Production Page 2
Molding as Innovative Technology for Personalized Tablet Production Page 3
Molding as Innovative Technology for Personalized Tablet Production Page 4
Molding as Innovative Technology for Personalized Tablet Production Page 5
Molding as Innovative Technology for Personalized Tablet Production Page 6
Molding as Innovative Technology for Personalized Tablet Production Page 7
Molding as Innovative Technology for Personalized Tablet Production Page 8
Molding as Innovative Technology for Personalized Tablet Production Page 9
Molding as Innovative Technology for Personalized Tablet Production Page 10
Molding as Innovative Technology for Personalized Tablet Production Page 11
Molding as Innovative Technology for Personalized Tablet Production Page 12

Download in electronic PDF format for $75

Abstract:  The future of dosage form design is expected to move towards the production of personalized dosage forms tailored to each patient. The 3D printer was introduced to solve that problem but is not easy to use in a pharmacy. Herein, a new 3D mold technology is adopted for tablet manufacturing. Preparation of amlodipine tablets was used as a Biopharmaceutics Classification System Class 1 drug model to study this technology. Different concentrations of either starch or Avicel-based formulations and different concentrations of hydroxypropyl methylcellulose as a binder for mass formation were used. The mass formed for each formula was cast into the mold for tablet preparation. Different non-pharmacopeial and pharmacopeial quality-control tests of the prepared tablets by using the 3D mold were compared to a marketed tablet product of amlodipine. 3D-molded tablets showed compliance properties with the tablet pharmacopeial quality standard. Studying the equivalence of the 3D mold tablets to the brand marketed product under biowaiver conditions was carried out. The difference and similarity factors studies of molded tablets prepared using starch or Avicel as a filler and 2.5% of hydroxypropyl methylcellulose showed acceptable characters to the drug brand name. It is predicted that by using this simple technique, it would be possible to produce tablets with designed disintegration and release profiles, which could potentially allow the tailoring of the drug release and hence personalize the medicine for each patient. 

Related Keywords: Omar Y. Mady, Assistant Professor, Adam A. Al-Shoubki, PhD - Scholar, Youssef Hagag, PhD, Bakry Ibrahim, MSc - Scholar, Ahmed A. Donia, Assistant Professor, personalized dosage forms, 3-dimensional printing, 3D printing, 3D molding, 3D mold casting, amlodipine, hypertension, high blood pressure, angina, chest pain, coronary artery disease, disintegration time, drug release, personalized medicine, tablet splitting, excipients, content uniformity, tablet hardness, tablet friability, dissolution profile

Related Categories: EXCIPIENTS, PEER-REVIEWED, TECHNOLOGY, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Molding as Innovative Technology for Personalized Tablet Production
Mady Omar Y
, Al-Shoubki Adam A, Hagag Youssef, Ibrahim Bakry, Donia Ahmed A
Mar/Apr 2022
Pg. 163-174

A Procedure for Tablet Production by Using the 3D Molding Technology and Powder Micromeritics Properties
Mady Omar
May/Jun 2022
Pg. 195-200

The Influence of Polymers, Surfactants, and Other Excipients on Naproxen Sodium Release from Matrices Prepared and the Effect of These Additives on the Swelling Rate of the Tablet
Alhmoud Hassan
, Akkam Yazan, Omari Derar, Alghananim Alaa, Melhem Mohammad Bani
Sep/Oct 2023
Pg. 431-439

Warfarin Personalized Dosage: Re-compounding for a More Suitable Therapy and Better Compliance
Pellagatti Tommaso
, Ternelli Marco, Frascio Davide, Bettini Ruggero
May/Jun 2017
Pg. 247-250

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Join the Partnership for Personalized Prescriptions (P3) Advocacy Effort!
Blankenship Cynthia
Nov/Dec 2017
Pg. 468

Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management
Soni Abhishek
, Gowthamarajan Kuppusamy, Radhakrishnan Arun
Mar/Apr 2018
Pg. 108-121

Pharmacists' Liability: What My Pharmacy Law Professor Did Not Cover
Rizo Mike
Jul/Aug 2013
Pg. 290-293

Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage
Kumaravelrajan Rajagopal
, Karthik B, Venkatasan Suba
Nov/Dec 2022
Pg. 516-521

Comparing Suppository Mold Variability Which Can Lead to Dosage Errors for Suppositories Prepared with the Same or Different Molds
Alexander Kenneth S
, Baki Gabriella, Hart Christine, Hejduk Courtney, Chillas Stephanie
Nov/Dec 2013
Pg. 512-514

Stability of Oral Liquid Dosage Forms of Ethacrynic Acid
Gupta Vishnu D
, Ling Jie
May/Jun 2001
Pg. 232-233

Stability of an Oral Liquid Dosage Form of Glycopyrrolate Prepared from Tablets
Gupta Vishnu D
Nov/Dec 2001
Pg. 480-481

Quality Control Analytical Methods: Considerations in Compounding Peroral Solid Dosage Forms
Vu Nicole
Mar/Apr 2007
Pg. 145-148

Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms
Bramwell Bethany L
Nov/Dec 2009
Pg. 498-505

Case Study: Personalized Oral Low-dose Naltrexone Titration for Pain Management
Rodriguez Franklin
, Carvalho Maria, Banov Fabiana
Nov/Dec 2023
Pg. 468-473

Extemporaneous Topical Minoxidil Solutions for the Treatment of Alopecia: Stability Studies and Incorporation Tests of Active Ingredients in ALOPLUS FAST Base
Spennacchio Antonio
, Lopedota Angela Assunta, Lopalco Antonio, Dibenedetto Maria Teresa, la Forgia Flavia Maria, Fontana Sergio, Franco Massimo, Denora Nunzio
May/Jun 2023
Pg. 256-262

Clinical Safety Profile of TrichoConcept™, a Line of Cosmetic Vehicles for Personalized Treatment of Alopecia
Marianni Bruna
, Polonini Hudson, Silva Carolina
Mar/Apr 2024
Pg. 169-175

Evaluation and Comparison of Wound Healing Properties of an Ointment (AlpaWash) Containing Brazilian Micronized Propolis and Peucedanum ostruthium Leaf Extract in Skin Ulcer in Rats
Nani Marcel
, Leone Andréia, Bom Vinícius Pedro, Buszinski Andrei Felipe, Oliveira de Souza Rebeca, Pinheiro Vanessa Alves, Danapoulos Panagiota, Swikidisa Rosita, Marquele-Oliveira Franciane, Cipriani Frade Marco Andrey, Berretta Andresa Aparecida, Nogueira Rodrigo José Lupatini
Mar/Apr 2018
Pg. 154-163

Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets
Mahesparan Vishnu A/L
, Bin Abd Razak Fashli Syafiq, Ming Long Chiau, Uddin ABM Helal, Sarker Md Zaidul Islam, Bin Liew Kai
Mar/Apr 2020
Pg. 148-155

An Alternative Approach to Tablet Splitting and Grinding for Medication Administration
Taneja Rajneesh
, Scarim Joseph, Pande Poonam G, Scarim Anthony, Nahata Milap C, Jew Rita K, Inabathina Koteswara Rao
May/Jun 2023
Pg. 240-249

Return to Top